- Home
- Drug Recall Enforcement Reports
- Recall Enforcement Event ID: 93456
Recall Enforment Report D-0411-2024
Recall Details
Multi event Drug Recall Enforcement Report Class II voluntary initiated by SCA Pharmaceuticals, LLC, originally initiated on 11-09-2023 for the product labetalol HCl 20 mg/4mL Injection, (Concentration=5 mg/mL), 4 mL fill Syringe, Rx Only, SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0700-28, Bar Code 70004070028 The product was recalled due to lack of assurance of sterility. The product was distributed nationwide and the recall is currently ongoing.
Recall Enforcement Reports
Recall Number | Recall Initiation Date | Report Date | Recall Classification | Quantity | Product Description | Recall Reason | Status |
---|---|---|---|---|---|---|---|
D-0411-2024 | 11-09-2023 | 04-03-2024 | Class II | 2,458, syringes | labetalol HCl 20 mg/4mL Injection, (Concentration=5 mg/mL), 4 mL fill Syringe, Rx Only, SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0700-28, Bar Code 70004070028 | Lack of Assurance of Sterility | Ongoing |
D-0399-2024 | 11-09-2023 | 04-03-2024 | Class II | 324 syringes | fentaNYL 100 mcg/50 mL, Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 50 mL Injection (fentaNYL Concentration = 2 mcg/mL), EPIDURAL USE ONLY, 50 mL fill Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd, Windsor, CT 06095, NDC 70004-0231-22, Bar Code 70004023122 | Lack of Assurance of Sterility | Ongoing |
D-0424-2024 | 11-09-2023 | 04-03-2024 | Class II | 5,079 syringe | SUCcinylcholine Chloride 100 mg/5mL Injection (Concentration = 20mg/mL), 5 mL fill 6 mL Syringe, Rx only, Repackaged by SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0908-09, Bar Code 70004090809 | Lack of Assurance of Sterility | Ongoing |
D-0394-2024 | 11-09-2023 | 04-03-2024 | Class II | 381 Bags | Diltiazem HCl 125 mg in 0.9% Sodium Chloride Injection (Concentration = 1mg/mL), 125 mL Bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095; NDC 70004-0541-35, Bar Code 70004054135 | Lack of Assurance of Sterility | Ongoing |
D-0413-2024 | 11-09-2023 | 04-03-2024 | Class II | 1,122 syringes | neostigmine methylsulfate 5 mg/5 mL Injection, (Concentration = 1mg/mL), 5 mL fill 6 mL Syringe, Rx Only, SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0750-09, Bar Code 70004075009 | Lack of Assurance of Sterility | Ongoing |
D-0410-2024 | 11-09-2023 | 04-03-2024 | Class II | 909 syringes | HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride Injection, (Concentration = 1mg/mL) 30 mL fill Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0303-21, Bar Code 70004030321 | Lack of Assurance of Sterility | Ongoing |
D-0415-2024 | 11-09-2023 | 04-03-2024 | Class II | 7,198 syringes; expanded 1,289 syringes | PHENYLephrine HCl 500 mcg/5 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 5 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0810-11, Bar Code 70004081011 | Lack of Assurance of Sterility | Ongoing |
D-0401-2024 | 11-09-2023 | 04-03-2024 | Class II | 130 cassettes | fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.075% in 0.9% Sodium Chloride 100 mL Injection (fentaNYL Concentration = 5 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0251-64, Bar Code 70004025164 | Lack of Assurance of Sterility | Ongoing |
D-0418-2024 | 11-09-2023 | 04-03-2024 | Class II | 10,017 syringes, expanded 2579 syringes | PHENYLephrine HCl 400 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 40 mcg/mL), 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0811-12, Bar Code 70004081112. | Lack of Assurance of Sterility | Ongoing |
D-0405-2024 | 11-09-2023 | 04-03-2024 | Class II | 5,734 syringes | HYDROmorphone HCl 6 mg/30 mL in 0.9% Sodium Chloride Injection, (Concentration = 0.2 mg/ml) 30 mL fill 35 mL Plungerless Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0300-16, Bar Code 70004030016 | Lack of Assurance of Sterility | Ongoing |
D-0422-2024 | 11-09-2023 | 04-03-2024 | Class II | 9,624 syringes | Sodium Citrate 4% 3 mL, Anticoagulation Solution Injection (Concentration = 40/mg/mL) 3mL fill Syringe, Repackaged by SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0900-25, Bar Code 70004090025 | Lack of Assurance of Sterility | Ongoing |
D-0421-2024 | 11-09-2023 | 04-03-2024 | Class II | 2,427 syringes | PHENYLephrine HCl 800 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 80mcg/mL) 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0816-12-K, Bar Code 700040081612. (same finished product as F078140, but with RFID for KitCheck compatibility) | Lack of Assurance of Sterility | Ongoing |
D-0395-2024 | 11-09-2023 | 04-03-2024 | Class II | 548 bags | fentaNYL 2,500 mcg/250 mL in 0.9% Sodium Chloride Injection (Concentration = 10 mcg/mL), 250 mL Bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, 877.550.5059, NDC 70004-0229-40 BAR code 70004022940 | Lack of Assurance of Sterility | Ongoing |
D-0404-2024 | 11-09-2023 | 04-03-2024 | Class II | 256 cassettes | HYDROmorphone HCl 20 mg/100mL in 0.9% Sodium Chloride Injection, 100 mL Grey CADD Cassette (20 mg/100 mL), CII, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0300-63, Bar Code 70004030063 | Lack of Assurance of Sterility | Ongoing |
D-0396-2024 | 11-09-2023 | 04-03-2024 | Class II | 500 bags | fentaNYL 2,500 mcg/50 mL Injection (Concentration = 50 mcg/mL), INTRAVENOUS USE ONLY, 50 mL Bag, Rx only, SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0222-30 BAR code 70004022230 | Lack of Assurance of Sterility | Ongoing |
D-0417-2024 | 11-09-2023 | 04-03-2024 | Class II | 5,948 syringes, expanded 2,102 syringes | PHENYLephrine HCl 5000 mcg/50 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 50 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0810-22, Bar Code 70004081022. | Lack of Assurance of Sterility | Ongoing |
D-0420-2024 | 11-09-2023 | 04-03-2024 | Class II | 3,671 syringes, expanded 1,911 syringes | PHENYLephrine HCl 800 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 80mcg/mL) 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0816-12, Bar Code 700040081612. | Lack of Assurance of Sterility | Ongoing |
D-0400-2024 | 11-09-2023 | 04-03-2024 | Class II | 412 cassettes | fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.04% in 0.9% Sodium Chloride 100 mL Injection (fentaNYL Concentration = 5 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0289-64, Bar Code 70004028964 | Lack of Assurance of Sterility | Ongoing |
D-0412-2024 | 11-09-2023 | 04-03-2024 | Class II | 1,508 bags; expanded 1,015 bags | Midazolam HCl 100 mg/100 mL in 0.9% Sodium Chloride Injection, (Concentration = 1mg/mL) 100 mL Bag, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0411-59, Bar Code 70004041159 | Lack of Assurance of Sterility | Ongoing |
D-0414-2024 | 11-09-2023 | 04-03-2024 | Class II | 33,072 syringes; expanded 9,041 syringes | PHENYLephrine HCl 1000 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0810-12, Bar Code 70004081012 | Lack of Assurance of Sterility | Ongoing |
D-0423-2024 | 11-09-2023 | 04-03-2024 | Class II | 8,755 syringe | SUCcinylcholine Chloride 200 mg/10mL Injection (Concentration = 20mg/mL), 10 mL fill 12 mL Syringe, Rx only, Repackaged by SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0908-12, Bar Code 70004090812 | Lack of Assurance of Sterility | Ongoing |
D-0419-2024 | 11-09-2023 | 04-03-2024 | Class II | 400 bags | PHENYLephrine HCl 40 mg in 0.9% Sodium Chloride Injection, (Concentration = 160 mcg/mL), 250 mL Bag, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0825-40, Bar Code 70004082540. | Lack of Assurance of Sterility | Ongoing |
D-0416-2024 | 11-09-2023 | 04-03-2024 | Class II | 1,118 syringes in kits | PHENYLephrine HCl 500 mcg/5 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 5 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0810-11-K, Bar Code 70004081011. (same finished product as F078140, but with RFID for KitCheck | Lack of Assurance of Sterility | Ongoing |
D-0398-2024 | 11-09-2023 | 04-03-2024 | Class II | 613 Cassettes | fentaNYL 200 mcg/100 mL, Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 100 mL Injection, (fentaNYL Concentration = 2 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0231-64, Bar Code 70004023164 | Lack of Assurance of Sterility | Ongoing |
D-0407-2024 | 11-09-2023 | 04-03-2024 | Class II | 1,023 syringes | HYDROmorphone HCl 10 mg/50 mL in 0.9% Sodium Chloride Injection (Concentration = 0.2 mg/ml) 50 mL fill Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0300-22, Bar Code 70004030022 | Lack of Assurance of Sterility | Ongoing |
D-0425-2024 | 11-09-2023 | 04-03-2024 | Class II | 368 bags | VANCOMYCIN 1.25 g added to 0.9% Sodium Chloride 250 mL Injection, 250 mL bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0923-59, Bar Code 70004092359 | Lack of Assurance of Sterility | Ongoing |
D-0409-2024 | 11-09-2023 | 04-03-2024 | Class II | 5392 syringes | HYDROmorphone HCl 30 mg/30mL in 0.9% Sodium Chloride Injection, (Concentration = 1 mg/ml) 30 mL fill 35 mL Plungerless Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0303-16, Bar Code 70004030316 | Lack of Assurance of Sterility | Ongoing |
D-0406-2024 | 11-09-2023 | 04-03-2024 | Class II | 1,425 syringes | HYDROmorphone HCl 6 mg/30 mL in 0.9% Sodium Chloride, (Concentration = 0.2mg/ml) 30 mL Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0300-18, Bar Code 70004030018 | Lack of Assurance of Sterility | Ongoing |
D-0397-2024 | 11-09-2023 | 04-03-2024 | Class II | 242 bags | fentaNYL 200 mcg/100 mL, Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 100 mL Injection (fentaNYL Concentration = 2 mcg/mL), EPIDURAL USE ONLY, 100 mL Bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0231-32, Bar Code 70004023132 | Lack of Assurance of Sterility | Ongoing |
D-0402-2024 | 11-09-2023 | 04-03-2024 | Class II | 1,259 syringes | fentaNYL 1,250 mcg/25 mL Injection (Concentration = 50 mcg/mL), 25 mL fill in a 30 mL Single Dose Syringe, RX Only, repackaged by SCA Pharma. SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0200-17, Bar code 70004020017 | Lack of Assurance of Sterility | Ongoing |
D-0403-2024 | 11-09-2023 | 04-03-2024 | Class II | 500 syringes | fentaNYL 2,500 mcg/50 mL in 0.9 % Sodium Chloride Injection (Concentration = 50 mcg/mL) 50 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0202-22, Bar code 70004020022, | Lack of Assurance of Sterility | Ongoing |
D-0408-2024 | 11-09-2023 | 04-03-2024 | Class II | 399 syringes | HYDROmorphone HCl 25 mg/25 mL in 0.9% Sodium Chloride Injection, (Concentration = 1mg/mL), 25 mL fill 30 mL Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0303-17, Bar Code 7004030317 | Lack of Assurance of Sterility | Ongoing |
Recall Enforcement Report D-0411-2024
Recall Enforcement Report D-0399-2024
Recall Enforcement Report D-0424-2024
Recall Enforcement Report D-0394-2024
Recall Enforcement Report D-0413-2024
Recall Enforcement Report D-0410-2024
Recall Enforcement Report D-0415-2024
Recall Enforcement Report D-0401-2024
Recall Enforcement Report D-0418-2024
Recall Enforcement Report D-0405-2024
Recall Enforcement Report D-0422-2024
Recall Enforcement Report D-0421-2024
Recall Enforcement Report D-0395-2024
Recall Enforcement Report D-0404-2024
Recall Enforcement Report D-0396-2024
Recall Enforcement Report D-0417-2024
Field Name | Field Value |
---|---|
Event ID | 93456 What is the Event ID? A numerical designation assigned by FDA to a specific recall event (used for tracking purposes). |
Recall Number | D-0417-2024 What is the Recall Number? An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes). |
Recall Classification | Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote What is the Recall Classification? Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified". |
Distribution Pattern | Nationwide in the USA What is the Distribution Pattern? General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included. |
Product Description | PHENYLephrine HCl 5000 mcg/50 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 50 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0810-22, Bar Code 70004081022. |
Reason For Recall | Lack of Assurance of Sterility What is the Reason for Recall? Information describing how the product is defective. |
Product Quantity | 5,948 syringes, expanded 2,102 syringes Product Quantity The amount of product subject to recall. |
Voluntary Mandated | Voluntary: Firm initiated Voluntary / Mandated Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order. |
Report Date | 04-03-2024 |
Recall Initiation Date | 11-09-2023 What is the Recall Initiation Date? The date that the firm first began notifying the public or their consignees of the recall. |
Initial Firm Notification | Letter Initial Firm Notification of Consignee or Public The method(s) by which the firm initially notified the public or their consignees of a recall. |
Product Type | Drugs |
Recalling Firm | SCA Pharmaceuticals, LLC |
Code Info | Lot #: 1223045282 Exp 11/24/23; 1223045370 Exp 11/26/23; 1223045624 Exp 12/07/23; 1223045723 Exp 12/10/23; 1223045732 Exp 12/10/23; 1223046128 Exp 12/24/23; 1223046133 Exp 12/24/23; 1223047112 Exp 02/02/24; 1223047232 Exp 2/07/24; 1223047398 Exp 02/15/24; 1223047456 Exp 02/16/24; 1223047569 Exp 02/18/24; 1223047694 Exp 02/24/24; 1223047780 Exp 03/07/24; 1223047859 Exp 03/08/24; 1223048119 Exp 03/20/24; 1223048183 Exp 03/22/24; 1223048837 Exp 04/18/24; 1223048838 Exp 04/18/24; 1223048982 Exp 04/24/24; 1223049144 Exp 05/02/24; 1223049145 Exp 05/02/24; 1223049147 Exp 05/02/24; 1223049821 Exp 05/30/24 Expanded Lot #: 1223048037, Exp 03/16/2024; 1223048047, Exp 03/17/2024; 1223049146, 1223049149, Exp 05/02/2024; 1223049373, Exp 05/10/2024; 1223048909, Exp 04/20/2024; 1223048696, Exp 04/12/2024; 1223050181, Exp 06/12/2024 Code Information A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling. |
Status | Ongoing |